cetirizine has been researched along with Allergic Reaction in 65 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine and compare the effects oral of DPH and cetirizine on the immediate- and late-phase cutaneous allergic reactions in healthy dogs." | 9.34 | Effect of diphenhydramine and cetirizine on immediate and late-phase cutaneous allergic reactions in healthy dogs: a randomized, double-blinded crossover study. ( Banovic, F; Blubaugh, A; Denley, T; Lemo, N; Papich, MG; Scheibe, I, 2020) |
| "The intensity and duration of early allergic reaction were not affected by cetirizine, whereas all parameters of late allergic reaction were statistically significantly improved in the cetirizine group when compared with those of the placebo group (maximum FEV1 decrease, p = 0." | 9.07 | Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. ( Leuenberger, P; Pécoud, A; Wasserfallen, JB, 1993) |
| "Levocetirizine (Xyzal) is a selective, potent, oral histamine H(1) receptor antagonist of the latest generation that is licensed for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis [PER]) and chronic idiopathic urticaria (CIU)." | 8.83 | Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. ( Hair, PI; Scott, LJ, 2006) |
| "Postcolitis rats displayed a higher number of colonic mast cells, excessive histamine release and significantly enhanced VMRs." | 7.80 | Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. ( De Man, JG; De Winter, BY; Deiteren, A; Moreels, TG; Pelckmans, PA; Ruyssers, NE, 2014) |
| "The purpose of this study was to assess the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients using rhinoscintigraphy." | 7.74 | Evaluation of the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients by rhinoscintigraphy. ( Seven, B; Sutbeyaz, Y; Varoglu, E; Yoruk, O, 2007) |
| "One hundred twenty women were followed after exposure to either hydroxyzine or cetirizine during pregnancy." | 7.69 | Prospective controlled study of hydroxyzine and cetirizine in pregnancy. ( Bailey, B; Baillie, M; Einarson, A; Jung, G; Koren, G; Spizzirri, D, 1997) |
| "Cetirizine is a selective H1 antagonist that inhibits the eosinophil recruitment induced by allergen in the skin." | 6.67 | Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. ( Chanez, P; Clauzel, AM; De Vos, C; Godard, P; Michel, FB; Rédier, H; Rifaï, N, 1992) |
| "Cetirizine hydrochloride was administered orally at 5 mg/cat, q24h, to 32 cats with allergic skin disease." | 5.38 | An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats. ( Griffin, JS; Miller, WH; Scott, DW; Tranchina, MM, 2012) |
| "To determine and compare the effects oral of DPH and cetirizine on the immediate- and late-phase cutaneous allergic reactions in healthy dogs." | 5.34 | Effect of diphenhydramine and cetirizine on immediate and late-phase cutaneous allergic reactions in healthy dogs: a randomized, double-blinded crossover study. ( Banovic, F; Blubaugh, A; Denley, T; Lemo, N; Papich, MG; Scheibe, I, 2020) |
| "Anti-inflammatory properties in 36%, allergy in anamnesis in 14% and allergic symptoms in 28% were pointed out by polish doctors as the main reasons for prescriptions of cetirizine." | 5.33 | [Cetirizine and respiratory tract infections in opinion of Polish doctors]. ( Jahnz-Rózyk, K, 2006) |
| "The intensity and duration of early allergic reaction were not affected by cetirizine, whereas all parameters of late allergic reaction were statistically significantly improved in the cetirizine group when compared with those of the placebo group (maximum FEV1 decrease, p = 0." | 5.07 | Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. ( Leuenberger, P; Pécoud, A; Wasserfallen, JB, 1993) |
| "Levocetirizine (Xyzal) is a selective, potent, oral histamine H(1) receptor antagonist of the latest generation that is licensed for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis [PER]) and chronic idiopathic urticaria (CIU)." | 4.83 | Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. ( Hair, PI; Scott, LJ, 2006) |
| "It has been demonstrated that cetirizine is able to reduce ICAM-1 expression on nasal epithelial cells and conjunctival nonspecific hyperreactivity in asthmatic asymptomatic children with MPI." | 4.80 | Minimal persistent inflammation may be controlled by cetirizine. ( Canonica, GW; Ciprandi, G, 1999) |
| " One of these, cetirizine, a human metabolite of hydroxyzine, is characterized by its high selectivity for the H1 receptor site and its reliable and consistent inhibition of histamine-induced allergic reactions." | 4.78 | Cetirizine: antiallergic therapy beyond traditional H1 antihistamines. ( Samuels, LL; Sheffer, AL, 1990) |
| "Postcolitis rats displayed a higher number of colonic mast cells, excessive histamine release and significantly enhanced VMRs." | 3.80 | Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. ( De Man, JG; De Winter, BY; Deiteren, A; Moreels, TG; Pelckmans, PA; Ruyssers, NE, 2014) |
| " and intracerebroventricular pentobarbital-induced sedation and alcohol-induced ataxia models." | 3.76 | Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H. ( Bagad, AS; Bahekar, PC; Chidrewar, GU; Mandhane, SN; Mehetre, SV; Pawar, CA; Rajamannar, T; Rao, CT; Shah, JH, 2010) |
| "The purpose of this study was to assess the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients using rhinoscintigraphy." | 3.74 | Evaluation of the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients by rhinoscintigraphy. ( Seven, B; Sutbeyaz, Y; Varoglu, E; Yoruk, O, 2007) |
| "In vivo antihistaminic activity experiments consisted of measurement of: inhibition of increase in capillary permeability and reduction in microvascular extravasation and bronchospasm in rats and guinea pigs induced by histamine and other inflammatory mediators; and protection against lethality induced by histamine and other inflammatory mediators in rats." | 3.73 | In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. ( Berisa, A; Corcóstegui, R; Innerárity, A; Labeaga, L; Orjales, A, 2006) |
| "One hundred twenty women were followed after exposure to either hydroxyzine or cetirizine during pregnancy." | 3.69 | Prospective controlled study of hydroxyzine and cetirizine in pregnancy. ( Bailey, B; Baillie, M; Einarson, A; Jung, G; Koren, G; Spizzirri, D, 1997) |
| "Levocetirizine 5 mg/day is an effective and well-tolerated treatment of PAR." | 2.71 | Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. ( Potter, PC, 2003) |
| "Experimental data demonstrate that mite allergy is characterized by persistent chronic inflammation." | 2.71 | Long-term cetirizine treatment may reduce new sensitisations in allergic children: a pilot study. ( Ciprandi, G; Frati, F; Marcucci, F; Milanese, M; Sensi, L; Tosca, MA, 2003) |
| " No differences in all-cause or treatment-related adverse events were observed between the cetirizine- and placebo-treated groups." | 2.71 | Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study. ( Catuogno, J; Chapman, D; Olufade, AO; Portnoy, JM; Silas, P; Simons, FE, 2003) |
| "Experimental data demonstrate that mite allergy is characterized by persistent chronic inflammation, even during asymptomatic periods." | 2.70 | Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. ( Canonica, GW; Ciprandi, G; Passalacqua, G; Tosca, M, 2001) |
| "Cetirizine is a selective H1 antagonist that inhibits the eosinophil recruitment induced by allergen in the skin." | 2.67 | Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. ( Chanez, P; Clauzel, AM; De Vos, C; Godard, P; Michel, FB; Rédier, H; Rifaï, N, 1992) |
| "With terfenadine, there were significant reductions in the levels of histamine and kinins (not measured in cetirizine study) seen after nasal challenge with antigen." | 2.66 | The effects of H1 antihistamines on the early allergic response. ( Baroody, F; Freidhoff, L; Kagey-Sobotka, A; Lichtenstein, LM; Naclerio, RM; Norman, PS; Proud, D, 1989) |
| " The compound shows a rapid onset of action, high bioavailability and affinity for the H1 receptor." | 2.45 | Levocetirizine in the treatment of allergic diseases. ( Baiardini, I; Canonica, GW; Compalati, E; Scordamaglia, A; Scordamaglia, F, 2009) |
| "The reference anti-allergy drugs, such as the inhaled corticosteroids or the cromones, without anti H1 activity, inhibit this late pulmonary response." | 2.38 | Pharmacological treatment of allergies. ( De Vos, C, 1992) |
| "However, the effect of anti-allergy therapy on MCNS remains unknown." | 1.56 | Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders. ( Fujii, T; Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Kawada, M; Mizuno, H; Oshima, Y; Sawa, N; Sekine, A; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y; Yamanouchi, M, 2020) |
| "Cetirizine was administered for 4 consecutive days to determine the effect on both histamine and allergen wheal and flare responses." | 1.48 | Reliability of allergy skin testing. ( Shtessel, M; Tversky, J, 2018) |
| "Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease." | 1.43 | A case of levocetirizine-induced liver injury. ( Cho, JY; Jung, MC; Kim, JK; Kim, SE; Lee, B; Park, JW; Seo, J; Song, JW, 2016) |
| "Cetirizine hydrochloride was administered orally at 5 mg/cat, q24h, to 32 cats with allergic skin disease." | 1.38 | An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats. ( Griffin, JS; Miller, WH; Scott, DW; Tranchina, MM, 2012) |
| "Levocetirizine was launched onto the UK market in September 2001." | 1.37 | Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data. ( Gilchrist, A; Layton, D; Osborne, V; Shakir, SA, 2011) |
| "The majority of women had a history of allergy (60%) and 10 of them (43%) had at least 1 positive result of a skin prick test to aeroallergens." | 1.33 | Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus fluconazole. ( Carvalho, EM; Carvalho, LP; Cruz, A; Lopes, AC; Neves, NA, 2005) |
| "Anti-inflammatory properties in 36%, allergy in anamnesis in 14% and allergic symptoms in 28% were pointed out by polish doctors as the main reasons for prescriptions of cetirizine." | 1.33 | [Cetirizine and respiratory tract infections in opinion of Polish doctors]. ( Jahnz-Rózyk, K, 2006) |
| "Cetirizine was effective in the treatment of allergic cough and mosquito bites; however, its precise role in these indications has yet to be clearly established." | 1.32 | Cetirizine: a review of its use in allergic disorders. ( Curran, MP; Perry, CM; Scott, LJ, 2004) |
| " The elimination half-life was 3." | 1.30 | Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers. ( Dab, I; de Longueville, M; Desager, JP; Harvengt, C; Hulhoven, R; Klánová, M; Spicák, V, 1997) |
| " The plasma elimination half-life of cetirizine was significantly shorter in children (p < 0." | 1.29 | A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children. ( Dab, I; Desager, JP; Harvengt, C; Horsmans, Y, 1993) |
| "Cetirizine is a new anti-allergic compound with a potent, long-acting, and specific antihistaminic property." | 1.28 | Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. ( Capron, A; Capron, M; De Vos, C; Joseph, M; Leprevost, C; Tomassini, M; Vorng, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.08) | 18.7374 |
| 1990's | 21 (32.31) | 18.2507 |
| 2000's | 27 (41.54) | 29.6817 |
| 2010's | 11 (16.92) | 24.3611 |
| 2020's | 4 (6.15) | 2.80 |
| Authors | Studies |
|---|---|
| Banovic, F | 1 |
| Denley, T | 1 |
| Blubaugh, A | 1 |
| Scheibe, I | 1 |
| Lemo, N | 1 |
| Papich, MG | 1 |
| Oshima, Y | 1 |
| Sumida, K | 1 |
| Yamanouchi, M | 1 |
| Hayami, N | 1 |
| Sekine, A | 1 |
| Mizuno, H | 1 |
| Kawada, M | 1 |
| Hiramatsu, R | 1 |
| Hasegawa, E | 1 |
| Suwabe, T | 1 |
| Hoshino, J | 1 |
| Sawa, N | 1 |
| Fujii, T | 1 |
| Takaichi, K | 1 |
| Ubara, Y | 1 |
| Bielory, L | 1 |
| Bhattacharyya, D | 1 |
| Shtessel, M | 1 |
| Tversky, J | 1 |
| Kamenica, E | 1 |
| Naclerio, R | 1 |
| Malani, A | 1 |
| Komatsuzaki, T | 1 |
| Suzaki, I | 1 |
| Hirano, K | 1 |
| Kanai, K | 1 |
| Asano, K | 1 |
| Suzaki, H | 1 |
| Deiteren, A | 1 |
| De Man, JG | 1 |
| Ruyssers, NE | 1 |
| Moreels, TG | 1 |
| Pelckmans, PA | 1 |
| De Winter, BY | 1 |
| Anvari, E | 1 |
| Wang, X | 1 |
| Sandler, S | 1 |
| Welsh, N | 1 |
| Jung, MC | 1 |
| Kim, JK | 1 |
| Cho, JY | 1 |
| Song, JW | 1 |
| Lee, B | 1 |
| Park, JW | 1 |
| Seo, J | 1 |
| Kim, SE | 1 |
| Müller, UR | 1 |
| Jutel, M | 1 |
| Reimers, A | 1 |
| Zumkehr, J | 1 |
| Huber, C | 1 |
| Kriegel, C | 1 |
| Steiner, U | 1 |
| Haeberli, G | 1 |
| Akdis, M | 1 |
| Helbling, A | 1 |
| Schnyder, B | 1 |
| Blaser, K | 1 |
| Akdis, C | 1 |
| Klimek, L | 1 |
| Scordamaglia, F | 1 |
| Compalati, E | 2 |
| Baiardini, I | 2 |
| Scordamaglia, A | 1 |
| Canonica, GW | 4 |
| Mandhane, SN | 1 |
| Shah, JH | 1 |
| Bahekar, PC | 1 |
| Mehetre, SV | 1 |
| Pawar, CA | 1 |
| Bagad, AS | 1 |
| Chidrewar, GU | 1 |
| Rao, CT | 1 |
| Rajamannar, T | 1 |
| Olsén, L | 1 |
| Bondesson, U | 1 |
| Broström, H | 1 |
| Olsson, U | 1 |
| Mazogi, B | 1 |
| Sundqvist, M | 1 |
| Tjälve, H | 1 |
| Ingvast-Larsson, C | 1 |
| Wolanczyk-Medrala, A | 1 |
| Gogolewski, G | 1 |
| Liebhart, J | 1 |
| Gomulka, K | 1 |
| Litwa, M | 1 |
| Panaszek, B | 1 |
| Lindner, K | 1 |
| Medrala, W | 1 |
| Cabrera-Freitag, P | 1 |
| Ferrer, M | 1 |
| Martínez, R | 1 |
| Javaloyes, G | 1 |
| Sanz, ML | 1 |
| Layton, D | 1 |
| Osborne, V | 1 |
| Gilchrist, A | 1 |
| Shakir, SA | 1 |
| Griffin, JS | 1 |
| Scott, DW | 1 |
| Miller, WH | 1 |
| Tranchina, MM | 1 |
| Simons, FE | 1 |
| Silas, P | 1 |
| Portnoy, JM | 1 |
| Catuogno, J | 1 |
| Chapman, D | 1 |
| Olufade, AO | 1 |
| Duchateau, J | 1 |
| Heenen, M | 1 |
| Sternon, J | 1 |
| Scheinfeld, N | 1 |
| Ciprandi, G | 3 |
| Frati, F | 1 |
| Marcucci, F | 1 |
| Sensi, L | 1 |
| Milanese, M | 1 |
| Tosca, MA | 1 |
| Potter, PC | 1 |
| Grzelewska-Rzymowska, I | 1 |
| Curran, MP | 1 |
| Scott, LJ | 2 |
| Perry, CM | 1 |
| Modrzyński, M | 1 |
| Zawisza, E | 1 |
| Rapiejko, P | 1 |
| Przybylski, G | 1 |
| Lipiec, A | 1 |
| Królikiewicz, J | 1 |
| Deruaz, C | 1 |
| Leimgruber, A | 1 |
| Berney, M | 1 |
| Pradervand, E | 1 |
| Spertini, F | 1 |
| Fumagalli, F | 1 |
| Pasquali, M | 1 |
| Guerra, L | 1 |
| Massacane, P | 1 |
| Neves, NA | 1 |
| Carvalho, LP | 1 |
| Lopes, AC | 1 |
| Cruz, A | 1 |
| Carvalho, EM | 1 |
| Hair, PI | 1 |
| Corcóstegui, R | 1 |
| Labeaga, L | 1 |
| Innerárity, A | 1 |
| Berisa, A | 1 |
| Orjales, A | 1 |
| Camelo-Nunes, IC | 1 |
| Seven, B | 1 |
| Yoruk, O | 1 |
| Varoglu, E | 1 |
| Sutbeyaz, Y | 1 |
| Jahnz-Rózyk, K | 1 |
| Spencer, CM | 1 |
| Faulds, D | 1 |
| Peters, DH | 1 |
| Poulsen, LK | 1 |
| Bindslev-Jensen, C | 1 |
| Rihoux, JP | 3 |
| Wasserfallen, JB | 1 |
| Leuenberger, P | 1 |
| Pécoud, A | 1 |
| Okada, C | 2 |
| Eda, R | 1 |
| Miyagawa, H | 1 |
| Sugiyama, H | 1 |
| Hopp, RJ | 1 |
| Bewtra, AK | 1 |
| Townley, RG | 2 |
| Desager, JP | 2 |
| Dab, I | 2 |
| Horsmans, Y | 1 |
| Harvengt, C | 2 |
| Ramboer, I | 1 |
| Fadel, R | 1 |
| Einarson, A | 1 |
| Bailey, B | 1 |
| Jung, G | 1 |
| Spizzirri, D | 1 |
| Baillie, M | 1 |
| Koren, G | 1 |
| Spicák, V | 1 |
| Hulhoven, R | 1 |
| Klánová, M | 1 |
| de Longueville, M | 2 |
| Arnold, R | 1 |
| König, B | 1 |
| König, W | 1 |
| Walsh, GM | 1 |
| Groschner, K | 1 |
| Pöch, G | 1 |
| Abdelaziz, MM | 1 |
| Khair, OA | 1 |
| Devalia, JL | 1 |
| Larsen, JS | 1 |
| Tosca, M | 1 |
| Passalacqua, G | 1 |
| Fridliand, DG | 1 |
| Gushchin, IS | 1 |
| Poroshina, IuA | 1 |
| Shul'zhenko, AE | 1 |
| Ollier, S | 1 |
| Rédier, H | 1 |
| Chanez, P | 1 |
| De Vos, C | 4 |
| Rifaï, N | 1 |
| Clauzel, AM | 1 |
| Michel, FB | 1 |
| Godard, P | 1 |
| Ryhal, BT | 1 |
| Fletcher, MP | 1 |
| Rivest, J | 1 |
| Despontin, K | 1 |
| Ghys, L | 1 |
| Lachapelle, JM | 1 |
| Bernheim, J | 1 |
| Arendt, C | 1 |
| Gleich, GJ | 1 |
| Sheffer, AL | 1 |
| Samuels, LL | 1 |
| Joseph, M | 1 |
| Leprevost, C | 1 |
| Vorng, H | 1 |
| Tomassini, M | 1 |
| Capron, M | 1 |
| Capron, A | 1 |
| Baroody, F | 1 |
| Proud, D | 1 |
| Kagey-Sobotka, A | 1 |
| Freidhoff, L | 1 |
| Norman, PS | 1 |
| Lichtenstein, LM | 1 |
| Naclerio, RM | 1 |
21 reviews available for cetirizine and Allergic Reaction
| Article | Year |
|---|---|
Levocetirizine: from scientific evidence to a potent modern-day treatment of today's allergic patients.
Topics: Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity | 2009 |
Levocetirizine in the treatment of allergic diseases.
Topics: Biological Availability; Cetirizine; Controlled Clinical Trials as Topic; Histamine H1 Antagonists, | 2009 |
[H1 histamine antagonists].
Topics: Acetates; Anti-Allergic Agents; Cetirizine; Chemistry, Pharmaceutical; Histamine H1 Antagonists; Hum | 2003 |
The new antihistamines--desloratadine and levocetirizine: a review.
Topics: Acetates; Animals; Area Under Curve; Cetirizine; Half-Life; Histamine H1 Antagonists, Non-Sedating; | 2002 |
[Clinical aspects of anti-inflammatory action of antihistamines].
Topics: Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivi | 2003 |
Antihistamines: do they work? Further well-controlled trials involving larger samples are needed.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; Histamine H1 Antagonists; Histamine H1 A | 2004 |
Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies.
Topics: Cetirizine; Clinical Trials as Topic; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivi | 2006 |
New antihistamines: a critical view.
Topics: Anti-Allergic Agents; Blood-Brain Barrier; Central Nervous System Diseases; Cetirizine; Child; Cypro | 2006 |
Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders.
Topics: Administration, Oral; Animals; Cetirizine; Clinical Trials as Topic; Half-Life; Humans; Hypersensiti | 1993 |
[Skin reactions to bradykinin].
Topics: Animals; Anti-Allergic Agents; Capillary Permeability; Cetirizine; Histamine Release; Humans; Hypers | 1995 |
G-proteins in allergy.
Topics: Cetirizine; GTP-Binding Proteins; Histamine H1 Antagonists; Humans; Hypersensitivity | 1997 |
The effects of cetirizine on the function of inflammatory cells involved in the allergic response.
Topics: Cetirizine; Endothelium; Epithelial Cells; Humans; Hypersensitivity; Immunity, Cellular; Leukocytes | 1997 |
[Cetirizine].
Topics: Anti-Allergic Agents; Cetirizine; Heart; Histamine H1 Antagonists; Humans; Hypersensitivity; Psychom | 1998 |
Minimal persistent inflammation may be controlled by cetirizine.
Topics: Animals; Anti-Allergic Agents; Asthma; Cetirizine; Child; Conjunctivitis, Allergic; Humans; Hypersen | 1999 |
What are the candidate groups for pharmacotherapeutic intervention to prevent asthma?
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child; Clinical Trials as Topic; Cromolyn Sodium; Dermatit | 2000 |
Do antihistamines have a role in asthma therapy?
Topics: Anti-Asthmatic Agents; Asthma; Bronchi; Cetirizine; Histamine; Histamine H1 Antagonists; Humans; Hyp | 2001 |
Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
Topics: Cetirizine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; | 1992 |
Pharmacological treatment of allergies.
Topics: Animals; Cetirizine; Drug Evaluation; Drug Evaluation, Preclinical; Guinea Pigs; Histamine H1 Antago | 1992 |
The second-generation antihistamines. What makes them different?
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Blood-Brain Barrier; Brain; Cetirizine; Cyprohepta | 1991 |
Cetirizine: more than an antihistamine?
Topics: Allergens; Animals; Asthma; Cetirizine; Exercise; Histamine Antagonists; Histamine H1 Antagonists; H | 1991 |
Cetirizine: antiallergic therapy beyond traditional H1 antihistamines.
Topics: Cetirizine; Diphenhydramine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; Reacti | 1990 |
15 trials available for cetirizine and Allergic Reaction
| Article | Year |
|---|---|
Effect of diphenhydramine and cetirizine on immediate and late-phase cutaneous allergic reactions in healthy dogs: a randomized, double-blinded crossover study.
Topics: Animals; Cetirizine; Cross-Over Studies; Diphenhydramine; Dog Diseases; Dogs; Double-Blind Method; H | 2020 |
Advertisements impact the physiological efficacy of a branded drug.
Topics: Adult; Advertising; Cetirizine; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; H | 2013 |
Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy.
Topics: Adolescent; Adult; Bee Venoms; Cetirizine; Desensitization, Immunologic; Double-Blind Method; Female | 2008 |
Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity.
Topics: Animals; Anti-Allergic Agents; Area Under Curve; Cetirizine; Dose-Response Relationship, Drug; Doubl | 2011 |
Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study.
Topics: Cetirizine; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Histamine H1 Antagonists | 2003 |
Long-term cetirizine treatment may reduce new sensitisations in allergic children: a pilot study.
Topics: Animals; Anti-Allergic Agents; Asthma; Cetirizine; Child; Child, Preschool; Double-Blind Method; Dus | 2003 |
Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites.
Topics: Adolescent; Adult; Animals; Cetirizine; Double-Blind Method; Dust; Female; Histamine H1 Antagonists, | 2003 |
[Efficacy of the medical treatment of adenoid hypertrophy in children with house dust mite allergy].
Topics: Adenoids; Administration, Intranasal; Administration, Topical; Androstadienes; Anti-Allergic Agents; | 2003 |
Levocetirizine better protects than desloratadine in a nasal provocation with allergen.
Topics: Adult; Albumins; Allergens; Biomarkers; Cetirizine; Cross-Over Studies; Differential Threshold; Doub | 2004 |
Quantitative determination of skin reactivity by two semiautomatic devices for skin prick test area measurements.
Topics: Cetirizine; Humans; Hypersensitivity; Image Processing, Computer-Assisted; Reproducibility of Result | 1994 |
Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen.
Topics: Adolescent; Adult; Asthma; Bronchial Provocation Tests; Cetirizine; Female; Histamine H1 Antagonists | 1993 |
Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy.
Topics: Allergens; Animals; Anti-Allergic Agents; Cetirizine; Child; Double-Blind Method; Female; Humans; Hy | 2001 |
Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma.
Topics: Administration, Inhalation; Adult; Allergens; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoa | 1992 |
Pharmacological modulation by cetirizine and ebastine of the cutaneous reactivity to histamine.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Butyrophenones; Capsules; Cetirizine; Double | 1991 |
The effects of H1 antihistamines on the early allergic response.
Topics: Benzhydryl Compounds; Calcium Channels; Cetirizine; Dopamine; Histamine H1 Antagonists; Humans; Hydr | 1989 |
29 other studies available for cetirizine and Allergic Reaction
| Article | Year |
|---|---|
Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Cetirizine; Cyclopropanes; Female; Histamine H1 Anta | 2020 |
Allergic inflammation of the anterior surface of the eye.
Topics: Adult; Cetirizine; Child; Conjunctivitis, Allergic; Eye; Histamine H1 Antagonists; Humans; Hypersens | 2020 |
Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2.
Topics: Acetates; Anti-Asthmatic Agents; Antiviral Agents; Cetirizine; Clinical Trials as Topic; COVID-19 Dr | 2020 |
Reliability of allergy skin testing.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Allergens; Cetirizine; Double-Blind Method; Fals | 2018 |
Suppression of osteopontin functions by levocetirizine, a histamine H1 receptor antagonist, in vitro.
Topics: Cetirizine; Histamine H1 Antagonists; Humans; Hypersensitivity; Nasal Mucosa; Osteopontin; RNA, Mess | 2013 |
Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity.
Topics: Animals; Cetirizine; Colitis; Colonoscopy; Convalescence; Disease Models, Animal; Histamine; Histami | 2014 |
The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice.
Topics: Animals; Autoimmunity; Blood Glucose; Cetirizine; Diabetes Mellitus, Experimental; Diet, High-Fat; F | 2015 |
A case of levocetirizine-induced liver injury.
Topics: Cetirizine; Chemical and Drug Induced Liver Injury; Histamine H1 Antagonists, Non-Sedating; Humans; | 2016 |
Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Topics: Acetates; Alcohols; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ataxia; Cetirizin | 2010 |
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorpha | 2009 |
A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine.
Topics: Adult; Animals; Antigens, CD; Antigens, Dermatophagoides; Antigens, Plant; Basophil Degranulation Te | 2009 |
The basophil activation test as a promising diagnostic tool in hypersensitivity to chironomid larvae.
Topics: Adult; Allergens; Animals; Antigens, CD; Basophils; Cetirizine; Chironomidae; Female; Histamine H1 A | 2011 |
Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cetirizine; Child; Drug Utilization; England; Female; Hi | 2011 |
An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats.
Topics: Administration, Oral; Animals; Antipruritics; Cat Diseases; Cats; Cetirizine; Female; Hypersensitivi | 2012 |
Cetirizine: a review of its use in allergic disorders.
Topics: Administration, Oral; Adult; Anti-Allergic Agents; Cetirizine; Child; Child, Preschool; Drug Adminis | 2004 |
Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus fluconazole.
Topics: Adult; Anti-Allergic Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Cetirizine; Female; Fluco | 2005 |
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
Topics: Animals; Benzimidazoles; Bradykinin; Bronchial Spasm; Capillary Permeability; Cetirizine; Dermatitis | 2006 |
Evaluation of the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients by rhinoscintigraphy.
Topics: Adult; Case-Control Studies; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hyp | 2007 |
[Cetirizine and respiratory tract infections in opinion of Polish doctors].
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Child, Preschool; Comorbidity; Dru | 2006 |
Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro.
Topics: Adult; Cetirizine; Chemotaxis, Leukocyte; Eosinophil Peroxidase; Eosinophils; Female; Humans; Hypers | 1994 |
A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.
Topics: Absorption; Adult; Cetirizine; Child, Preschool; Female; Half-Life; Humans; Hypersensitivity; Male; | 1993 |
Prospective controlled study of hydroxyzine and cetirizine in pregnancy.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Alcohol Drinking; Anti-Allergic Agents; Birth Rate; Bi | 1997 |
Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Topics: Administration, Oral; Area Under Curve; Cetirizine; Female; Histamine H1 Antagonists; Humans; Hypers | 1997 |
The potential of active metabolites of antihistamines in the management of allergic disease.
Topics: Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Cetirizine; Chymases; Eosinophils; Granul | 2000 |
Newer antihistamines.
Topics: Administration, Oral; Anti-Allergic Agents; Cetirizine; Chlorpheniramine; Conscious Sedation; Diphen | 2001 |
[Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Cetirizine; Clemastine; Female; Histamine H1 Antagonist | 2002 |
Cutaneous responses--a window on inflammatory processes.
Topics: Cetirizine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; Inflammation; Skin | 1992 |
Why do allergic individuals accumulate more eosinophils at the site of an IgE-mediated reaction than do normal subjects?
Topics: Cetirizine; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; Immunoglob | 1990 |
Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
Topics: Blood Platelets; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Cytotoxicity, Immunologic; Eos | 1989 |